A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
Prescient Therapeutics, Ltd.
Prescient Therapeutics, Ltd.
University of Pittsburgh
Fondazione Italiana Linfomi - ETS
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
SciTech Development, Inc.
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Lund University Hospital
Peking University First Hospital